2006
DOI: 10.1016/j.fitote.2006.09.004
|View full text |Cite
|
Sign up to set email alerts
|

Hypolipemic effect of water extracts of Picrorrhiza kurroa in high fat diet treated mouse

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 31 publications
1
16
0
Order By: Relevance
“…In this study, MLE dose-dependently ameliorated gene expressions of LXRa, LPL, SREBP1c, FAS, C/EBPa, and aP2 and protein levels of nuclear SREBP1c and cytosolic LPL. A previous study demonstrated that Nrf2 activation inhibited up-regulated LXRa activity and LXRa-dependent liver steatosis (Lee et al 2006). Collectively, the results of the current study suggest that MLE attenuates lipid accumulation through the decrease in LXRa-dependent lipogenesis and the increase in lipolysis in HFD-induced NAFLD.…”
Section: Discussionsupporting
confidence: 72%
See 1 more Smart Citation
“…In this study, MLE dose-dependently ameliorated gene expressions of LXRa, LPL, SREBP1c, FAS, C/EBPa, and aP2 and protein levels of nuclear SREBP1c and cytosolic LPL. A previous study demonstrated that Nrf2 activation inhibited up-regulated LXRa activity and LXRa-dependent liver steatosis (Lee et al 2006). Collectively, the results of the current study suggest that MLE attenuates lipid accumulation through the decrease in LXRa-dependent lipogenesis and the increase in lipolysis in HFD-induced NAFLD.…”
Section: Discussionsupporting
confidence: 72%
“…NAFLD is a common chronic liver disease that includes fibrosis, steatosis, hepatocellular ballooning, and inflammation (Hey-Mogensen et al 2012). NAFLD is a progressive disease and is characterized by the accumulation of TG in the liver (Lee et al 2006) caused by obesity and imbalanced diets such as an excessive high-fat or calories diet (HFD). For that reason, NAFLD is accompanied with abnormal lipid metabolism with down-regulation of fatty acid b-oxidation, lipolysis, and increased lipogenesis (Enjoji et al 2012).…”
Section: Introductionmentioning
confidence: 99%
“…It has been reported to have hepatoprotective, anticholestatic, antioxidant, and immune-modulating effects, among others [2][3][4][5]. Picroside II (b-D-glucopyranoside-1a,1b,2,5a,6,6a-hexahydro-6-[(4-hydroxy-3-methoxybenzoyl)oxy]-1a-(hydroxymethyl)oxireno [4,5]cyclopenta [1,2-c]pyran-2-yl; Fig. 1) is one of the main active constituents.…”
Section: Introductionmentioning
confidence: 99%
“…Liver weight, serum aspartate transferase (AST), alanine transferase (ALT ), low density lipoprotein (LDL), triglyceride and total cholesterol levels were significantly reduced by the treatment. On the contrary, serum HDL level seems not affected by P. kurroa water extract (Lee et al, 2008).…”
Section: Hypolipemic Activitymentioning
confidence: 79%
“…But due to our sedentary lifestyle and dietary habits, our liver gets affected by several diseases like cirrhosis of liver, jaundice, hepatitis B, gall bladder stones, etc. Kutki is mainly known for its hepatoprotective properties, jaundice, bile disorders and other ailments of liver (Lee et al, 2008). …”
Section: Main Uses Of Kutki Is Referred In Liver Diseasesmentioning
confidence: 99%